Community-acquired methicillin-resistant Staphylococcus aureus pneumonia and ARDS: 1-year follow-up.
Reported infections due to methicillin-resistant Staphylococcus aureus (MRSA) are increasing. Although most of these cases are skin and skin structure infections, necrotizing pneumonias also have been reported. Recently, reports of community-acquired MRSA (CA-MRSA) pneumonia have documented that it is a severe necrotizing pneumonia and often is fatal. To our knowledge, no previous reports have examined the long-term recovery of patients who have had this condition. We present a case of confirmed CA-MRSA necrotizing pneumonia with post-hospital discharge follow-up involving radiologic imaging and pulmonary function testing.
Napolitano
Lena M
LM
Division of Acute Care Surgery, Department of Surgery, Department of Medicine, University of Michigan, Ann Arbor, MI. Electronic address: lenan@umich.edu.
Brunsvold
Melissa E
ME
Division of Acute Care Surgery, Department of Surgery, Department of Medicine, University of Michigan, Ann Arbor, MI.
Reddy
Raju C
RC
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI.
Hyzy
Robert C
RC
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D017714:Community-Acquired Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D005845:Georgia / Q000453:epidemiology; D006801:Humans; D007251:Influenza, Human / Q000453:epidemiology; D008145:Louisiana / Q000453:epidemiology; D055624:Methicillin-Resistant Staphylococcus aureus; D011014:Pneumonia / Q000000981:diagnostic imaging / Q000453:epidemiology*; D013902:Radiography, Thoracic; D012128:Respiratory Distress Syndrome / Q000453:epidemiology*; D013203:Staphylococcal Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology*; D014481:United States
D000900:Anti-Bacterial Agents